About Beijing Hotgen Biotech Co.,Ltd Company

The company was founded in June 2005 and is a high-tech biological enterprise with the mission of “developing biotechnology to benefit human health”. The company continues to explore independent innovative diagnostic technology platforms, actively develop and expand early screening technology for liquid biopsy cancer, and establish a multi-omics diagnostic technology platform including protein markers, glycochain exosomes, and DNA methylation; at the same time, it has established a future technology research institute to explore cutting-edge technology, actively lay out biopharmaceutical fields such as antibody drugs, active bacterial drugs, exosomal drugs, etc., and create a development strategy for the entire industry chain from diagnosis to treatment. The company is a high-tech biotechnology enterprise with the mission of “developing biotechnology for the benefit of human health”. The company's main products are in vitro diagnostic products and bioinnovative drugs. The company has won more than 60 honorary titles such as “Beijing Enterprise Technology Center”, “Beijing Intellectual Property Operation Pilot Unit”, “Beijing Intellectual Property Demonstration Unit”, and “Beijing Key Laboratory for Biological Emergency and Clinical POCT”; the products developed by the company won the second prize of the National Technological Invention Award, the second prize of the Beijing Science and Technology Award, the second prize of the “Shanghai Science and Technology Award”, the second prize of the Chinese Medical Science and Technology Award, the second prize of the Chinese Medical Science and Technology Award, and the gold medal for outstanding innovative products in vitro diagnosis. The company has won honors such as the “Outstanding Practice Case of Listed Company Directors” issued by the China Association of Listed Companies, the “Most Popular Listed Company” by Huashun and the “Outstanding Investment and Construction Award for Listed Companies” by Value Online.